Since we could not eliminate MLL-ALL cells with dexamethasone alone, we assessed whether additional inhibition of SFKs and FLT3 leads to more efficient killing of leukemic cells in vivo. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.